Results 31 to 40 of about 83,665 (235)

Leishmaniasis in refugee and local Pakistani populations. [PDF]

, 2004
The epidemiology of anthroponotic cutaneous leishmaniasis was investigated in northwest Pakistan. Results suggested similar patterns of endemicity in both Afghan refugee and Pakistani populations and highlighted risk factors and household clustering of ...
Said Agha, Mark Rowland, Rowland, Mark, Brooker, Simon, Jan Kolaczinski, Adil, Khaksar, Mohammed, Nasir, Simon Brooker, Reithinger, Richard, Kolaczinski, Jan, Nasir Mohammed, Agha, Said, Khaksar Adil, Richard Reithinger, Ali, Iftikhar, Iftikhar Ali   +15 more
core   +1 more source

Leishmaniasis [PDF]

The Lancet, 1999
In 1903, Leishman and Donovan separately described the protozoan now called Leishmania donovani in splenic tissue from patients in India with the life-threatening disease now called visceral leishmaniasis. Almost a century later, many features of leishmaniasis and its major syndromes (ie, visceral, cutaneous, and mucosal) have remained the same; but ...
openaire   +3 more sources

Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. [PDF]

, 2012
BACKGROUND: Cutaneous leishmaniasis is a vector-borne disease that is in Ethiopia mainly caused by the parasite Leishmania aethiopica. This neglected tropical disease is common in rural areas and causes serious morbidity.
Cloke, T, Abebe Tamrat, Mekonen Woinshet, Modolell, M, Thomas Cloke, Woldeyes Mihretu, Seich Al Basatena, Nafisa-Katrin, Abebe, T., Corware, Karina, Bilcha, K, Seich al Basatena, N., Munder, M, Lionel Fry, Tacchini-Cottier, F, Ingrid Müller, Kropf, P, Müller, Ingrid, Markus Munder, Bilcha, K., Fry Lionel, Seich Al Basatena, N.K., Cloke Thomas, Hailu, A., Cloke, Thomas, Mueller, I, Mihretu Woldeyes, Pascale Kropf, Müller Ingrid, Mekonen, Woinshet, Karina Corware, Modolell, Manuel, al Basatena, N-KS, Müller, I., Woldeyes, M, Woinshet Mekonen, Corware, K, Asrat Hailu, Kassahun Bilcha, Corware Karina, Abebe, T, Woldeyes, Mihretu, Munder, Markus, Manuel Modolell, Mekonen, W., Hailu, A, Modolell Manuel, Fry, Lionel, Kropf Pascale, Abebe, Tamrat, Fry, L., Fry, L, Corware, K., Cloke, T., Modolell, M., Munder, M., Tacchini-Cottier, Fabienne, Fabienne Tacchini-Cottier, Kropf, P., Kropf, Pascale, Bilcha, Kassahun, Tacchini-Cottier, F., Woldeyes, M., Munder Markus, Nafisa-Katrin Seich Al Basatena, Mekonen, W, Tacchini-Cottier Fabienne, Hailu Asrat, Hailu, Asrat, Tamrat Abebe, Bilcha Kassahun, Seich al Basatena Nafisa-Katrin   +70 more
core   +1 more source

Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. [PDF]

, 2003
A prevalence survey in Kabul City showed that 2.7% and 21.9% of persons have active leishmaniasis lesions or scars, respectively. Incidence of disease was estimated to be 2.9% (29 cases/1,000 persons per year; 95% confidence interval 0.018 to 0.031 ...
Reithinger, Richard, Panna Erasmus, Erasmus, Panna, Coleman, Paul G, Aadil, Khoksar, Paul G. Coleman, Sidiqi, Majeed, Mohsen, Mohammad, Richard Reithinger, Majeed Sidiqi, Mohammad Mohsen, Khoksar Aadil   +11 more
core   +1 more source

Oral miltefosine for Indian visceral leishmaniasis. [PDF]

, 2002
BACKGROUND: There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost all untreated patients die, and all the effective agents have been parenteral.
Berman, Jonathan, Thakur, C. P., Sundar, Shyam, Junge, Klaus, Thakur, CP, Bryceson, Anthony, Engel, Juergen, Sindermann, Herbert, Jha, TK, Jha, T. K., Fischer, Christina   +10 more
core   +1 more source

Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan

Journal of Tropical Medicine, 2013
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that affects more than 50% of successfully treated visceral leishmaniasis (VL) patients in Sudan.
A. M. Musa, E. A. G. Khalil, B. M. Younis, M. E. E. Elfaki, M. Y. Elamin, A. O. A. Adam, H. A. A. Mohamed, M. M. M. Dafalla, A. A. Abuzaid, A. M. El-Hassan   +9 more
doaj   +1 more source

Leishmaniasis [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
SummaryLeishmaniasis is a clinically heterogeneous group of diseases, caused by infection with protozoa of the genus Leishmania. The aggressiveness of the individual species, their organ preference and the host immune status determine disease course.
openaire   +2 more sources

Assessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. [PDF]

, 2001
Using a capture-recapture method, this study evaluates the completeness of the cutaneous leishmaniasis (CL) surveillance system in four districts of Santiago del Estero province, Argentina, for the period 1990-1993. Four reporting sources were evaluated:
Yadón, ZE, E L Segura, Z E Yadón, Yadón, Zaida E., L C Rodrigues, Quigley, MA, Davies, CR, Rodrigues, LC, C R Davies, Segura, Elsa L., Segura, Elsa Leonor, Quigley, Maria A., Quigley, Maria, M A Quigley, Rodrigues, Laura C., Davies, Clive R., Segura, EL   +16 more
core   +1 more source

Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran

International Journal for Parasitology: Drugs and Drug Resistance, 2023
Leishmaniasis is an overlooked, poverty-stricken, and complex disease with growing social and public health problems. In general, leishmaniasis is a curable disease; however, there is an expansion of unresponsive cases to treatment in cutaneous ...
Mehdi Bamorovat, Iraj Sharifi, Setareh Agha Kuchak Afshari, Ali Karamoozian, Amirhossein Tahmouresi, Amireh Heshmatkhah, Ehsan Salarkia, Ahmad Khosravi, Maryam Hakimi Parizi, Maryam Barghi   +9 more
doaj   +1 more source

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment

Annals of Saudi Medicine, 2014
BACKGROUND AND OBJECTIVES: Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In Sudan, VL is caused by L donovani. Most drugs used to treat VL, especially pentavalent antimony compounds (sodium stibogluconate, SSG),
Abubakr O. A. Adam, Mohamed M. M. Dafalla, Hatim A. A. Mohammed, Mohamed Y. Elamin, Brima M. Younis, Mona E. E. Elfaki, Ahmed M. Musa, Ahmed M. Elhassan, Eltahir A. G. Khalil   +8 more
doaj   +1 more source